| Secondary |
| Schizophrenia |
26.4% |
| Depression |
15.8% |
| Insomnia |
9.7% |
| Product Used For Unknown Indication |
8.1% |
| Drug Use For Unknown Indication |
7.2% |
| Anxiety |
6.6% |
| Constipation |
5.0% |
| Bipolar Disorder |
2.7% |
| Dementia Alzheimer's Type |
2.7% |
| Personality Disorder |
2.5% |
| Restlessness |
2.5% |
| Pneumonia |
1.6% |
| Suicide Attempt |
1.4% |
| Bipolar I Disorder |
1.2% |
| Confusional State |
1.2% |
| Obsessive-compulsive Disorder |
1.2% |
| Extrapyramidal Disorder |
1.1% |
| Mania |
1.1% |
| Schizophrenia, Paranoid Type |
1.1% |
| Sedation |
1.1% |
|
| Vomiting |
11.3% |
| Pulmonary Oedema |
10.0% |
| Renal Failure Acute |
8.8% |
| Suicide Attempt |
8.8% |
| Overdose |
6.3% |
| Hypotonia Neonatal |
5.0% |
| Pulmonary Alveolar Haemorrhage |
5.0% |
| Sudden Death |
5.0% |
| Thinking Abnormal |
5.0% |
| Tremor Neonatal |
5.0% |
| Cardio-respiratory Arrest |
3.8% |
| Restlessness |
3.8% |
| Somnolence |
3.8% |
| Urinary Tract Infection |
3.8% |
| Granulocyte Count Decreased |
2.5% |
| Lung Disorder |
2.5% |
| Off Label Use |
2.5% |
| Platelet Count Decreased |
2.5% |
| Postresuscitation Encephalopathy |
2.5% |
| Rhabdomyolysis |
2.5% |
|
| Concomitant |
| Schizophrenia |
37.6% |
| Depression |
7.9% |
| Insomnia |
7.8% |
| Constipation |
5.6% |
| Product Used For Unknown Indication |
5.0% |
| Bipolar I Disorder |
4.9% |
| Dysthymic Disorder |
4.1% |
| Drug Use For Unknown Indication |
3.9% |
| Anxiety |
3.8% |
| Bipolar Disorder |
2.9% |
| Schizophrenia, Paranoid Type |
2.7% |
| Sleep Disorder |
2.4% |
| Hyperlipidaemia |
2.0% |
| Pain |
1.7% |
| Hypertension |
1.4% |
| Prophylaxis |
1.4% |
| Akathisia |
1.2% |
| Dissociative Disorder |
1.2% |
| Extrapyramidal Disorder |
1.2% |
| Irritability |
1.2% |
|
| Neuroleptic Malignant Syndrome |
10.2% |
| Suicide Attempt |
8.6% |
| White Blood Cell Count Increased |
8.6% |
| Shock |
7.8% |
| Off Label Use |
6.3% |
| Psychiatric Symptom |
6.3% |
| Death |
5.5% |
| Pyrexia |
4.7% |
| Pancytopenia |
3.9% |
| Pneumonia |
3.9% |
| Rhabdomyolysis |
3.9% |
| Somnolence |
3.9% |
| Tremor |
3.9% |
| Weight Increased |
3.9% |
| Blood Creatine Phosphokinase Increased |
3.1% |
| Completed Suicide |
3.1% |
| Hypertension |
3.1% |
| Overdose |
3.1% |
| Psychomotor Hyperactivity |
3.1% |
| Rash |
3.1% |
|
| Interacting |
| Schizophrenia |
65.6% |
| Constipation |
19.7% |
| Pneumonia |
6.6% |
| Ileus |
3.3% |
| Insomnia |
3.3% |
| Megacolon |
1.6% |
|
| Ileus Paralytic |
33.3% |
| Sepsis |
33.3% |
| Vomiting |
33.3% |
|
